Avalyn Pharma AVLN Insider Ownership

Updated Oct 10, 2026

Over the past year, AVLN insiders bought $20 million of stock (1.11Mn shares) on the open market and sold none.

• Behind Avalyn Pharma's open-market purchases in the past 12 months were 2 insiders, and no insider sold.
• Among Avalyn Pharma's insiders, the largest open-market purchases in the past 12 months were by Novo Holdings A/S (10% owner), totaling $10 million (555.55K shares), most recently on May 1, 2026.
• Apart from open-market trades, AVLN insiders acquired 9.64Mn shares through option exercises and conversions in the past 12 months.
• Per Business Quant data, Avalyn Pharma insiders hold 10.75Mn shares in total based on their latest Form 4 filings, or 24.25% of the 44.33Mn shares outstanding; that total is unchanged from 10.75Mn shares at the end of Q2 2026.
• Of the 10.75Mn shares held by Avalyn Pharma insiders, 5.16Mn shares (47.98%) are held directly and 5.59Mn shares (52.02%) indirectly, through trusts, partnerships, family members and other entities.
• The insider holdings in Avalyn Pharma belong to 5 insiders who have reported on Form 4 within the past two years.
• Avalyn Pharma's three biggest insider holders are Novo Holdings A/S (10% owner, 3.88Mn shares), FMR LLC (10% owner, 2.28Mn shares) and Jill Carroll (Director, 2.19Mn shares), based on their latest Form 4 filings.
• Of the shares held by AVLN insiders, 36.12% belong to Novo Holdings A/S.
• Over the past 12 months, 15 insiders reported transactions in Avalyn Pharma stock in 15 Form 4 filings.
• These insider figures for Avalyn Pharma are based on Form 4 filings through September 17, 2026.